India's pharmaceutical industry anticipates a 9% annual growth rate for FY25-FY27, potentially reaching $70 billion by FY27.
India's pharmaceutical industry is set for substantial growth, driven by strong domestic and export market performance, anticipating a 9% annual growth rate for FY25-FY27, potentially pushing its value beyond $70 billion (₹5.81 lakh crore) by FY27. The sector has demonstrated a robust CAGR of around 8% from FY18 to FY24, with exports growing by 8% and domestic market by 7%. In FY24, the industry expanded by 9%, reaching an estimated $54 billion (₹4.48 lakh crore).
June 30, 2024
3 Articles